|
|
|
|
|
|
|
Opiant Pharmaceuticals- Inc. (OPNT)
|
|
15.92 0.52 (3.38%)
|
06-19 09:35
|
|
Open:
|
15.4
|
Pre. Close:
|
15.4
|
|
High:
|
16
|
Low:
|
15.4
|
|
Volume:
|
790
|
Market Cap:
|
43M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
15.773 - 15.861
|
15.861 - 15.942
|
|
Low:
|
15.097 - 15.212
|
15.212 - 15.318
|
|
Close:
|
15.234 - 15.4
|
15.4 - 15.552
|
|
|
|
Technical analysis (as of: 2018-06-19 10:07:03 AM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 19.70  One year: 21.02
|
|
Support:
|
Support1: 15.04 Support2: 12.51
|
|
Resistance:
|
Resistance1:
16.87 Resistance2: 18.00
|
|
Pivot:
|
15.75
|
|
Moving Averages:
|
MA(5): 15.50 MA(20): 15.99
MA(100): 19.49 MA(250): 23.27
|
|
MACD:
|
MACD(12,26):
-0.68 Signal(12,26,9): -0.77
|
|
%K %D:
|
%K(14,3): 21.68 %D(3): 16.67
|
|
RSI:
|
RSI(14): 44.94
|
|
52-Week:
|
High: 51.9
Low: 5.06 Change(%): 179.3
|
|
Average Vol(K):
|
3-Month: 2286
10-Days 1513
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.OPNT has closed below upper band by 40.7%. Bollinger Bands are 56.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to OPNT's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-05-16T16:44:42-04:00
FDA OKs first non-opioid treatment for opioid withdrawal
2018-05-08T17:13:50-04:00
Opiant Pharmaceuticals reports Q1 results
2018-04-26T03:18:20-04:00
Opioid prescriptions dropped 12% in 2017
2018-04-19T11:25:01-04:00
U.S. opioid prescriptions down 12% last year, largest drop in 25 years
2018-04-17T15:35:03-04:00
DEA aiming to collar production of opioids
2018-04-17T12:03:04-04:00
Sen. Sanders introduces bill to fine opioid makers for marketing practices
2018-04-11T05:49:01-04:00
Will Opiant Pharma Solve The Biggest Crisis That The FDA Is Currently Facing?
2018-03-20T14:56:08-04:00
Technology - Top Gainers / Losers as of 2.55 pm (3/20/18)
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
